KEGG   PATHWAY: oro05200
Entry
oro05200                    Pathway                                
Name
Pathways in cancer - Odobenus rosmarus divergens (Pacific walrus)
Class
Human Diseases; Cancer: overview
Pathway map
oro05200  Pathways in cancer
oro05200

Organism
Odobenus rosmarus divergens (Pacific walrus) [GN:oro]
Gene
101374183  DCC; netrin receptor DCC [KO:K06765]
101371336  CASP3; caspase-3 isoform X2 [KO:K02187] [EC:3.4.22.56]
101362812  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
101375582  APPL1; DCC-interacting protein 13-alpha [KO:K08733]
101375608  CDH1; cadherin-1 [KO:K05689]
101378737  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
101372726  CTNNA2; catenin alpha-2 isoform X2 [KO:K05691]
101363402  CTNNA1; catenin alpha-1 isoform X2 [KO:K05691]
101375084  AXIN1; axin-1 [KO:K02157]
101362548  AXIN2; axin-2 isoform X1 [KO:K04385]
101372249  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
101371790  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
101365718  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
101376237  TCF7; transcription factor 7 isoform X3 [KO:K02620]
101382778  TCF7L1; transcription factor 7-like 1 [KO:K04490]
101385846  TCF7L2; transcription factor 7-like 2 isoform X3 [KO:K04491]
101372325  LEF1; lymphoid enhancer-binding factor 1 isoform X2 [KO:K04492]
101363894  BIRC5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
101369253  MYC; myc proto-oncogene protein [KO:K04377]
101371532  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
101370511  WNT1; proto-oncogene Wnt-1 [KO:K03209]
101364222  WNT2; protein Wnt-2 [KO:K00182]
101373643  WNT2B; protein Wnt-2b [KO:K00182]
101381764  WNT3A; protein Wnt-3a [KO:K00312]
101374826  WNT3; proto-oncogene Wnt-3 [KO:K00312]
101365138  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
101364119  WNT5B; protein Wnt-5b [KO:K00444]
101378764  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
101374890  WNT6; protein Wnt-6 [KO:K00445]
101386348  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
101381717  WNT7A; protein Wnt-7a [KO:K00572]
101365801  WNT8B; protein Wnt-8b [KO:K00714]
101370196  WNT8A; protein Wnt-8a [KO:K00714]
101377699  WNT9A; protein Wnt-9a [KO:K01064]
101375113  WNT9B; protein Wnt-9b [KO:K01064]
101375180  WNT10A; protein Wnt-10a [KO:K01357]
101370799  WNT10B; protein Wnt-10b [KO:K01357]
101386420  WNT11; protein Wnt-11 [KO:K01384]
101381671  WNT16; protein Wnt-16 [KO:K01558]
101381417  FZD7; frizzled-7 [KO:K02432]
101383526  FZD1; frizzled-1 [KO:K02432]
101368846  FZD2; frizzled-2 [KO:K02235]
101377153  FZD3; frizzled-3 [KO:K02329]
101374073  FZD4; frizzled-4 [KO:K02354]
101381761  FZD5; frizzled-5 [KO:K02375]
101364672  FZD8; frizzled-8 [KO:K02375]
101378848  FZD6; frizzled-6 isoform X1 [KO:K02376]
101368911  FZD9; frizzled-9 [KO:K02842]
101371262  FZD10; frizzled-10 [KO:K02842]
101386248  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
101385538  LRP6; low-density lipoprotein receptor-related protein 6 isoform X1 [KO:K03068]
101362760  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
101380123  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
101375453  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
101365631  FRAT1; proto-oncogene FRAT1 [KO:K03069]
101370444  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
101381460  F2; prothrombin [KO:K01313] [EC:3.4.21.5]
101373565  AGT; angiotensinogen [KO:K09821]
101364644  F2R; proteinase-activated receptor 1 [KO:K03914]
101369923  F2RL3; proteinase-activated receptor 4 isoform X2 [KO:K04236]
101371767  LPAR1; lysophosphatidic acid receptor 1 isoform X1 [KO:K04289]
101363634  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
101363176  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]
101363180  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
101377363  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
101386667  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
101377034  AGTR1; type-1 angiotensin II receptor [KO:K04166]
101371250  GNA12; guanine nucleotide-binding protein subunit alpha-12 isoform X1 [KO:K04346]
101386508  GNA13; guanine nucleotide-binding protein subunit alpha-13 isoform X1 [KO:K04639]
101372821  ARHGEF12; rho guanine nucleotide exchange factor 12 [KO:K07532]
101364107  ARHGEF11; rho guanine nucleotide exchange factor 11 [KO:K12331]
101377895  ARHGEF1; rho guanine nucleotide exchange factor 1 [KO:K12330]
101375686  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
101383468  RHOA; transforming protein RhoA isoform X1 [KO:K04513]
101386230  ROCK1; rho-associated protein kinase 1 isoform X2 [KO:K04514] [EC:2.7.11.1]
101372971  ROCK2; rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.1]
101378047  CXCL12; stromal cell-derived factor 1 isoform X1 [KO:K10031]
101372091  CXCR4; C-X-C chemokine receptor type 4 isoform X1 [KO:K04189]
101376186  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 isoform X1 [KO:K04630]
101367568  GNAI3; guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630]
101367936  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X1 [KO:K04630]
101385186  PTGER1; prostaglandin E2 receptor EP1 subtype [KO:K04258]
101379988  PTGER2; prostaglandin E2 receptor EP2 subtype [KO:K04259]
101371218  PTGER3; prostaglandin E2 receptor EP3 subtype [KO:K04260]
101367485  PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
101364060  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
105757053  neuroendocrine secretory protein 55 [KO:K04632]
101379158  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
101365382  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
101368682  ADCY3; adenylate cyclase type 3 [KO:K08043] [EC:4.6.1.1]
101374313  ADCY4; adenylate cyclase type 4 [KO:K08044] [EC:4.6.1.1]
101380824  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
101373816  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
101377421  ADCY7; adenylate cyclase type 7 [KO:K08047] [EC:4.6.1.1]
101370350  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
101364108  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
101367408  PRKACB; cAMP-dependent protein kinase catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
101383001  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
101381482  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 isoform X1 [KO:K04536]
101378633  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 isoform X1 [KO:K04537]
101371845  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
101369300  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
101362117  GNB5; guanine nucleotide-binding protein subunit beta-5 isoform X1 [KO:K04539]
101366315  GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
101376879  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
101369684  GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
101365462  GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
101363588  GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
101371482  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
101370001  GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
101375712  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
101379027  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
101374080  GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
101368814  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7-like [KO:K04347]
101382152  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
101375999  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 isoform X1 [KO:K04548]
101386155  GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
101366517  COL4A3; collagen alpha-3(IV) chain [KO:K06237]
101367094  COL4A4; collagen alpha-4(IV) chain [KO:K06237]
101373882  COL4A6; collagen alpha-6(IV) chain [KO:K06237]
101373537  COL4A5; collagen alpha-5(IV) chain [KO:K06237]
101378777  COL4A1; collagen alpha-1(IV) chain [KO:K06237]
101381103  COL4A2; collagen alpha-2(IV) chain [KO:K06237]
101383157  LAMA2; laminin subunit alpha-2 [KO:K05637]
101364310  LAMA1; laminin subunit alpha-1 [KO:K05637]
101370639  LAMA5; laminin subunit alpha-5 [KO:K06240]
101386047  LAMA3; laminin subunit alpha-3 [KO:K06240]
101369714  laminin subunit alpha-4 [KO:K06241]
101382657  LAMB1; laminin subunit beta-1 isoform X2 [KO:K05636]
101380776  LAMB2; laminin subunit beta-2 [KO:K06243]
101368738  LAMB3; laminin subunit beta-3 [KO:K06244]
101382364  LAMB4; laminin subunit beta-4 [KO:K06245]
101384210  LAMC1; laminin subunit gamma-1 [KO:K05635]
101384487  LAMC2; laminin subunit gamma-2 [KO:K06246]
101369468  LAMC3; laminin subunit gamma-3 [KO:K06247]
101365197  FN1; fibronectin isoform X1 [KO:K05717]
101375601  ITGA2; integrin alpha-2 [KO:K06481]
101369639  ITGA2B; integrin alpha-IIb isoform X1 [KO:K06476]
101366550  ITGA3; integrin alpha-3 isoform X1 [KO:K06482]
101383404  ITGA6; integrin alpha-6 isoform X1 [KO:K06485]
101368762  ITGAV; integrin alpha-V isoform X1 [KO:K06487]
101385291  ITGB1; integrin beta-1 isoform X1 [KO:K05719]
101371010  PTK2; focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
101370689  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
101385241  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
101385267  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
101374787  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
101370100  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
101371800  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
101367385  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
101364398  NKX3-1; homeobox protein Nkx-3.1 isoform X1 [KO:K09348]
101383166  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
101382320  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
101374757  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
101364103  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha [KO:K04467] [EC:2.7.11.10]
101375346  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
101384959  IKBKG; NF-kappa-B essential modulator isoform X2 [KO:K07210]
101384149  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
101371488  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
101381073  NFKB2; nuclear factor NF-kappa-B p100 subunit [KO:K04469]
101381225  RELA; transcription factor p65 [KO:K04735]
101375484  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
101380967  NOS2; nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
101372267  BCL2; apoptosis regulator Bcl-2 [KO:K02161]
101372845  BIRC3; baculoviral IAP repeat-containing protein 3 [KO:K16060]
101373139  BIRC2; baculoviral IAP repeat-containing protein 2 [KO:K16060]
101367150  XIAP; E3 ubiquitin-protein ligase XIAP isoform X1 [KO:K04725] [EC:2.3.2.27]
101368853  BIRC7; baculoviral IAP repeat-containing protein 7 [KO:K16061]
101380440  BCL2L1; bcl-2-like protein 1 isoform X1 [KO:K04570]
101364536  TRAF1; TNF receptor-associated factor 1 [KO:K03172]
101371938  TRAF2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
101374855  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
101366008  TRAF4; TNF receptor-associated factor 4 [KO:K09848]
101373241  TRAF5; TNF receptor-associated factor 5 isoform X1 [KO:K09849]
101362953  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
101363844  MTOR; LOW QUALITY PROTEIN: serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
101381996  RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X2 [KO:K04688] [EC:2.7.11.1]
101365998  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
101375422  BAD; bcl2-associated agonist of cell death [KO:K02158]
101373912  FOXO1; forkhead box protein O1 [KO:K07201]
101385402  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
101362427  TP53; cellular tumor antigen p53 [KO:K04451]
101362774  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
101375107  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
101362630  BCR; breakpoint cluster region protein [KO:K08878] [EC:2.7.11.1]
101370651  ABL1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
101369015  CRKL; crk-like protein [KO:K04438]
101384062  CRK; adapter molecule crk isoform X1 [KO:K04438]
101377544  CBL; E3 ubiquitin-protein ligase CBL [KO:K04707] [EC:2.3.2.27]
101372719  STAT5A; signal transducer and activator of transcription 5A isoform X1 [KO:K11223]
101372217  STAT5B; signal transducer and activator of transcription 5B isoform X2 [KO:K11224]
101372024  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
101383457  PIM2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
101375897  KNG1; kininogen-1 isoform X1 [KO:K03898]
101377023  EDN1; endothelin-1 isoform X2 [KO:K16366]
101383369  BDKRB1; B1 bradykinin receptor [KO:K03915]
101383657  BDKRB2; B2 bradykinin receptor [KO:K03916]
101363432  EDNRA; endothelin-1 receptor isoform X1 [KO:K04197]
101375015  EDNRB; endothelin B receptor isoform X1 [KO:K04198]
101384596  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
101385358  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
101379806  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 [KO:K05858] [EC:3.1.4.11]
101375710  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
101386162  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X2 [KO:K05858] [EC:3.1.4.11]
101386750  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
101386060  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
101380879  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
101363254  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
101386196  IL2; interleukin-2 [KO:K05429]
101384443  IL4; interleukin-4 [KO:K05430]
101383696  IL5; interleukin-5 [KO:K05428]
101377851  IL6; interleukin-6 isoform X1 [KO:K05405]
101374293  IL7; interleukin-7 isoform X1 [KO:K05431]
101367178  IL12A; interleukin-12 subunit alpha [KO:K05406]
101372789  IL12B; interleukin-12 subunit beta isoform X1 [KO:K05425]
101365728  IL13; interleukin-13 [KO:K05435]
101372500  IL15; interleukin-15 isoform X1 [KO:K05433]
101367844  IL23A; interleukin-23 subunit alpha [KO:K05426]
101379507  EPO; erythropoietin isoform X1 [KO:K05437]
101377641  interferon alpha-1/2-like [KO:K05414]
101378214  IFNA5; interferon alpha-5 [KO:K05414]
101374322  interferon alpha-1/2-like [KO:K05414]
101374610  interferon alpha-14-like [KO:K05414]
101379735  interferon beta-like [KO:K05414]
101382125  IFNG; interferon gamma [KO:K04687]
101378506  IL2RA; interleukin-2 receptor subunit alpha [KO:K05068]
101366322  IL2RB; interleukin-2 receptor subunit beta [KO:K05069]
101374379  IL2RG; cytokine receptor common subunit gamma [KO:K05070]
101383763  IL3RA; LOW QUALITY PROTEIN: interleukin-3 receptor subunit alpha [KO:K04737]
101373228  IL4R; interleukin-4 receptor subunit alpha [KO:K05071]
101363658  CSF2RB; cytokine receptor common subunit beta [KO:K04738]
101373063  IL5RA; interleukin-5 receptor subunit alpha [KO:K05067]
101368251  IL6R; interleukin-6 receptor subunit alpha [KO:K05055]
101368221  IL6ST; interleukin-6 receptor subunit beta isoform X1 [KO:K05060]
101385299  IL7R; interleukin-7 receptor subunit alpha [KO:K05072]
101372587  IL12RB1; interleukin-12 receptor subunit beta-1 [KO:K05063]
101376489  IL12RB2; interleukin-12 receptor subunit beta-2 isoform X1 [KO:K05064]
101371898  IL13RA1; interleukin-13 receptor subunit alpha-1 isoform X2 [KO:K05076]
101378787  IL15RA; interleukin-15 receptor subunit alpha [KO:K05074]
101377662  IL23R; interleukin-23 receptor [KO:K05065]
101385485  EPOR; erythropoietin receptor [KO:K05079]
101370046  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
101386107  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
101375882  IFNGR1; interferon gamma receptor 1 [KO:K05132]
101370021  EML4; echinoderm microtubule-associated protein-like 4 isoform X2 [KO:K15420]
101373502  ALK; ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
101372513  RASGRP1; RAS guanyl-releasing protein 1 isoform X1 [KO:K04350]
101369676  RASGRP2; RAS guanyl-releasing protein 2 [KO:K12361]
101371588  RASGRP3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
101365772  RASGRP4; RAS guanyl-releasing protein 4 [KO:K12363]
101365648  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
101375007  JAK2; tyrosine-protein kinase JAK2 isoform X1 [KO:K04447] [EC:2.7.10.2]
101369142  JAK3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
101373587  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
101378785  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
101368050  STAT2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221]
101379077  STAT4; signal transducer and activator of transcription 4 [KO:K11222]
101375468  STAT6; signal transducer and activator of transcription 6 isoform X1 [KO:K11225]
101363442  VEGFA; vascular endothelial growth factor A [KO:K05448]
101377548  VEGFB; vascular endothelial growth factor B [KO:K16858]
101369724  PGF; placenta growth factor [KO:K16859]
101372364  FIGF; vascular endothelial growth factor D [KO:K05449]
101375487  VEGFC; vascular endothelial growth factor C [KO:K05449]
101384783  TGFA; protransforming growth factor alpha isoform X1 [KO:K08774]
101377629  EGF; LOW QUALITY PROTEIN: pro-epidermal growth factor [KO:K04357]
101386858  EGFR; epidermal growth factor receptor isoform X2 [KO:K04361] [EC:2.7.10.1]
101364161  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
101386160  PDGFA; platelet-derived growth factor subunit A isoform X1 [KO:K04359]
101370194  PDGFB; platelet-derived growth factor subunit B isoform X2 [KO:K17386]
101372359  PDGFRA; platelet-derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
101374793  PDGFRB; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
101386334  IGF1; insulin-like growth factor I isoform X1 [KO:K05459]
101384061  IGF2; LOW QUALITY PROTEIN: insulin-like growth factor II [KO:K13769]
101386211  IGF1R; insulin-like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
101378811  KITLG; kit ligand isoform X1 [KO:K05461]
101372059  KIT; mast/stem cell growth factor receptor Kit isoform X7 [KO:K05091] [EC:2.7.10.1]
101383895  FLT3LG; fms-related tyrosine kinase 3 ligand [KO:K05454]
101382975  FLT3; receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
101373766  HGF; hepatocyte growth factor isoform X1 [KO:K05460]
101365730  MET; hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
101363195  FGF1; fibroblast growth factor 1 isoform X1 [KO:K18496]
101369428  FGF2; LOW QUALITY PROTEIN: fibroblast growth factor 2 [KO:K18497]
101377940  FGF7; fibroblast growth factor 7 isoform X1 [KO:K04358]
101370946  FGF4; fibroblast growth factor 4 [KO:K04358]
101379461  FGF18; fibroblast growth factor 18 [KO:K04358]
101379943  FGF20; fibroblast growth factor 20 [KO:K04358]
101382345  FGF5; fibroblast growth factor 5 isoform X1 [KO:K04358]
101366748  FGF10; fibroblast growth factor 10 [KO:K04358]
101385349  FGF3; fibroblast growth factor 3 [KO:K04358]
101382205  FGF22; fibroblast growth factor 22 [KO:K04358]
101366655  FGF16; fibroblast growth factor 16 [KO:K04358]
101373546  FGF8; fibroblast growth factor 8 isoform X1 [KO:K04358]
101379430  FGF17; fibroblast growth factor 17 isoform X1 [KO:K04358]
101381072  FGF9; fibroblast growth factor 9 [KO:K04358]
101364070  FGF6; fibroblast growth factor 6 [KO:K04358]
101385649  FGF19; fibroblast growth factor 19 [KO:K22603]
101373782  FGF21; fibroblast growth factor 21 [KO:K22429]
101363779  FGF23; fibroblast growth factor 23 [KO:K22428]
101364849  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
101381278  FGFR2; fibroblast growth factor receptor 2 isoform X2 [KO:K05093] [EC:2.7.10.1]
101381434  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
101381264  FGFR4; fibroblast growth factor receptor 4 isoform X2 [KO:K05095] [EC:2.7.10.1]
101362094  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
101385114  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
101369947  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
101367134  GTPase HRas-like [KO:K02833]
101372786  HRAS; GTPase HRas isoform X1 [KO:K02833]
101370458  KRAS; GTPase KRas isoform X2 [KO:K07827]
101363525  NRAS; GTPase NRas [KO:K07828]
101372839  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
101377465  BRAF; serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
101372149  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X2 [KO:K04366] [EC:2.7.11.1]
101365373  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
101376586  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
101372573  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
101382213  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
101368207  JUN; transcription factor AP-1 isoform X1 [KO:K04448]
101366773  FOS; proto-oncogene c-Fos isoform X1 [KO:K04379]
101372127  ETS1; protein C-ets-1 isoform X1 [KO:K02678]
101371070  LOW QUALITY PROTEIN: interstitial collagenase-like [KO:K01388] [EC:3.4.24.7]
101369292  interstitial collagenase-like [KO:K01388] [EC:3.4.24.7]
101378425  MMP2; 72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
101380511  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
101365039  CXCL8; interleukin-8 [KO:K10030]
101362330  CDK4; cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
101380272  RPS6KA5; ribosomal protein S6 kinase alpha-5 [KO:K04445] [EC:2.7.11.1]
101372117  RET; proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
101366394  CCDC6; coiled-coil domain-containing protein 6 [KO:K09288]
101380526  NCOA4; nuclear receptor coactivator 4 isoform X2 [KO:K09289]
101374117  NTRK1; high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
101378465  TPM3; tropomyosin alpha-3 chain isoform X1 [KO:K09290]
101376535  TPR; nucleoprotein TPR [KO:K09291]
101379554  TFG; protein TFG isoform X1 [KO:K09292]
101370893  RASSF1; ras association domain-containing protein 1 isoform X3 [KO:K09850]
101367106  RASSF5; ras association domain-containing protein 5 isoform X1 [KO:K08015]
101382383  STK4; serine/threonine-protein kinase 4 isoform X1 [KO:K04411]
101377929  DAPK3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
101365336  DAPK1; death-associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]
101375783  DAPK2; death-associated protein kinase 2 [KO:K08803] [EC:2.7.11.1]
101380728  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2 [KO:K01116] [EC:3.1.4.11]
101378505  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
101373422  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
101373722  calmodulin-alpha-like [KO:K02183]
101384567  CALML4; LOW QUALITY PROTEIN: calmodulin-like protein 4 [KO:K02183]
101376564  CALML5; calmodulin-like protein 5 [KO:K02183]
101370824  CALML6; calmodulin-like protein 6 [KO:K02183]
101376265  CALML3; calmodulin-like protein 3 [KO:K02183]
101371788  CALM3; calmodulin [KO:K02183]
101386691  calmodulin-like [KO:K02183]
101372085  calmodulin-A-like [KO:K02183]
101379187  CALM1; calmodulin isoform X1 [KO:K02183]
101366685  CALM2; calmodulin isoform X1 [KO:K02183]
101375584  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta [KO:K04515] [EC:2.7.11.17]
101375944  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
101367567  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X2 [KO:K04515] [EC:2.7.11.17]
101384300  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
101386629  RALGDS; ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732]
101364360  RALA; ras-related protein Ral-A [KO:K07834]
101379049  RALB; ras-related protein Ral-B [KO:K07835]
101380359  RALBP1; ralA-binding protein 1 [KO:K08773]
101364638  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
101378519  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
101366544  LOW QUALITY PROTEIN: ras-related C3 botulinum toxin substrate 1-like [KO:K04392]
101385830  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
101374128  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
101383564  PLD2; phospholipase D2 isoform X1 [KO:K01115] [EC:3.1.4.4]
101369263  PLD1; phospholipase D1 isoform X1 [KO:K01115] [EC:3.1.4.4]
101367488  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
101374143  MAPK8; mitogen-activated protein kinase 8 isoform X3 [KO:K04440] [EC:2.7.11.24]
101376185  MAPK9; mitogen-activated protein kinase 9 isoform X2 [KO:K04440] [EC:2.7.11.24]
101366440  PAX8; paired box protein Pax-8 isoform X1 [KO:K09293]
101370284  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
101365135  RXRA; retinoic acid receptor RXR-alpha isoform X2 [KO:K08524]
101373938  RXRB; retinoic acid receptor RXR-beta isoform X3 [KO:K08525]
101363350  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
101376899  RARB; retinoic acid receptor beta isoform X3 [KO:K08528]
101376152  ESR1; estrogen receptor isoform X2 [KO:K08550]
101380427  ESR2; estrogen receptor beta isoform X1 [KO:K08551]
101369582  NCOA1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
101363340  NCOA3; nuclear receptor coactivator 3 [KO:K11256] [EC:2.3.1.48]
101367562  SP1; transcription factor Sp1 isoform X1 [KO:K04684]
101363250  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
101365540  JUP; junction plakoglobin [KO:K10056]
101365084  ZBTB16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
101381332  RARA; retinoic acid receptor alpha isoform X1 [KO:K08527]
101371477  CCNA1; cyclin-A1 [KO:K06627]
101363224  CCNA2; cyclin-A2 isoform X1 [KO:K06627]
101365827  PML; protein PML [KO:K10054] [EC:2.3.2.-]
101367976  RUNX1; runt-related transcription factor 1 [KO:K08367]
101379574  RUNX1T1; protein CBFA2T1 isoform X1 [KO:K10053]
101375564  SPI1; transcription factor PU.1 isoform X2 [KO:K09438]
101368354  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
101383473  CSF2RA; granulocyte-macrophage colony-stimulating factor receptor subunit alpha [KO:K05066]
105757391  granulocyte-macrophage colony-stimulating factor receptor subunit alpha-like [KO:K05066]
101377969  CSF3R; granulocyte colony-stimulating factor receptor [KO:K05061]
101374504  CSF1R; macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
101366721  E2F1; transcription factor E2F1 [KO:K17454]
101368301  E2F2; transcription factor E2F2 [KO:K09389]
101371945  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
101385122  MAX; protein max isoform X1 [KO:K04453]
101384400  ZBTB17; zinc finger and BTB domain-containing protein 17 isoform X2 [KO:K10500]
101378405  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
101363193  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
101372891  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
101375203  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
101373551  CKS1B; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
101374307  S-phase kinase-associated protein 1 [KO:K03094]
101386391  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
101369645  CUL1; cullin-1 [KO:K03347]
101363104  RBX1; E3 ubiquitin-protein ligase RBX1 isoform X1 [KO:K03868] [EC:2.3.2.32]
101383205  SKP2; S-phase kinase-associated protein 2 isoform X1 [KO:K03875]
101383299  CDK2; cyclin-dependent kinase 2 isoform X2 [KO:K02206] [EC:2.7.11.22]
101366323  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
101382136  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
101386367  RB1; retinoblastoma-associated protein [KO:K06618]
101374376  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X1 [KO:K04402]
101374334  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
101363875  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
101371652  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
101380231  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
101378738  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
101367509  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
101386324  TERT; telomerase reverse transcriptase isoform X1 [KO:K11126] [EC:2.7.7.49]
101372297  MITF; microphthalmia-associated transcription factor isoform X2 [KO:K09455]
101385166  TGFB1; transforming growth factor beta-1 [KO:K13375]
101380860  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
101364584  TGFB3; transforming growth factor beta-3 [KO:K13377]
101379465  TGFBR1; TGF-beta receptor type-1 isoform X2 [KO:K04674] [EC:2.7.11.30]
101364575  TGFBR2; TGF-beta receptor type-2 [KO:K04388] [EC:2.7.11.30]
101385419  SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
101367515  SMAD3; mothers against decapentaplegic homolog 3 [KO:K23605]
101374152  SMAD4; mothers against decapentaplegic homolog 4 [KO:K04501]
101384287  MECOM; MDS1 and EVI1 complex locus protein EVI1 isoform X4 [KO:K04462] [EC:2.1.1.367]
101384122  CTBP1; C-terminal-binding protein 1 [KO:K04496] [EC:1.1.1.428]
101386387  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
101365273  HDAC2; histone deacetylase 2 isoform X1 [KO:K06067] [EC:3.5.1.98]
101384069  HDAC1; histone deacetylase 1 isoform X1 [KO:K06067] [EC:3.5.1.98]
101366332  MLH1; DNA mismatch repair protein Mlh1 isoform X2 [KO:K08734]
101367758  MSH2; DNA mismatch repair protein Msh2 [KO:K08735]
101381286  MSH3; DNA mismatch repair protein Msh3 [KO:K08736]
101368929  MSH6; DNA mismatch repair protein Msh6 isoform X1 [KO:K08737]
101364023  BRCA2; breast cancer type 2 susceptibility protein [KO:K08775]
101370313  RAD51; DNA repair protein RAD51 homolog 1 [KO:K04482]
101381319  FASLG; tumor necrosis factor ligand superfamily member 6 isoform X1 [KO:K04389]
101369551  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
101385048  FADD; FAS-associated death domain protein [KO:K02373]
101365855  CASP8; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
101371120  BID; BH3-interacting domain death agonist [KO:K04726]
101362130  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
101366869  BBC3; bcl-2-binding component 3 [KO:K10132]
101378922  BCL2L11; bcl-2-like protein 11 isoform X2 [KO:K16341]
101386882  LOW QUALITY PROTEIN: cytochrome c, testis-specific-like [KO:K08738]
101386944  cytochrome c [KO:K08738]
101383104  APAF1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
101363955  CASP7; caspase-7 isoform X1 [KO:K04397] [EC:3.4.22.60]
101378046  KEAP1; kelch-like ECH-associated protein 1 [KO:K10456]
101384719  NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638]
101364369  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
101379965  NQO1; NAD(P)H dehydrogenase [quinone] 1 [KO:K00355] [EC:1.6.5.2]
101364329  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
101377307  glutathione S-transferase theta-1-like [KO:K00799] [EC:2.5.1.18]
101377874  glutathione S-transferase theta-1 isoform X1 [KO:K00799] [EC:2.5.1.18]
101378163  glutathione S-transferase theta-1-like isoform X1 [KO:K00799] [EC:2.5.1.18]
101375310  glutathione S-transferase A2 [KO:K00799] [EC:2.5.1.18]
101375600  GSTA4; glutathione S-transferase A4 [KO:K00799] [EC:2.5.1.18]
101379260  glutathione S-transferase A1-like [KO:K00799] [EC:2.5.1.18]
101379552  LOW QUALITY PROTEIN: glutathione S-transferase-like [KO:K00799] [EC:2.5.1.18]
101377040  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
101365935  GSTM3; glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
101376323  GSTO1; glutathione S-transferase omega-1 isoform X1 [KO:K00799] [EC:2.5.1.18]
101376797  GSTO2; glutathione S-transferase omega-2 isoform X1 [KO:K00799] [EC:2.5.1.18]
101368726  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
101376063  LOW QUALITY PROTEIN: glutathione S-transferase Mu 1 [KO:K00799] [EC:2.5.1.18]
101377598  glutathione S-transferase theta-4 [KO:K00799] [EC:2.5.1.18]
101363382  glutathione S-transferase P [KO:K23790] [EC:2.5.1.18]
101363675  glutathione S-transferase P-like [KO:K23790] [EC:2.5.1.18]
101386257  TXNRD1; thioredoxin reductase 1, cytoplasmic [KO:K22182] [EC:1.8.1.9]
101375144  TXNRD3; thioredoxin reductase 3 isoform X1 [KO:K22182] [EC:1.8.1.9]
101380068  TXNRD2; thioredoxin reductase 2, mitochondrial [KO:K22182] [EC:1.8.1.9]
101370163  VHL; von Hippel-Lindau disease tumor suppressor isoform X1 [KO:K03871]
101365614  TCEB1; transcription elongation factor B polypeptide 1 [KO:K03872]
101379627  TCEB2; transcription elongation factor B polypeptide 2 [KO:K03873]
101379527  LOW QUALITY PROTEIN: cullin-2-like [KO:K03870]
101374279  CUL2; cullin-2 [KO:K03870]
101377787  EGLN1; egl nine homolog 1 [KO:K09592] [EC:1.14.11.29]
101367839  EGLN3; egl nine homolog 3 isoform X1 [KO:K09592] [EC:1.14.11.29]
101368021  EGLN2; egl nine homolog 2 [KO:K09592] [EC:1.14.11.29]
101363872  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
101374637  HIF1A; hypoxia-inducible factor 1-alpha isoform X1 [KO:K08268]
101362839  EPAS1; endothelial PAS domain-containing protein 1 [KO:K09095]
101371497  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
101382914  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 [KO:K15589]
101362815  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
101386879  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
101365014  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
101380408  JAG1; protein jagged-1 isoform X2 [KO:K06052]
101384304  JAG2; protein jagged-2 isoform X1 [KO:K21635]
101367445  DLL4; delta-like protein 4 isoform X2 [KO:K06051]
101379005  DLL3; LOW QUALITY PROTEIN: delta-like protein 3 [KO:K06051]
101382088  DLL1; delta-like protein 1 [KO:K06051]
101380913  NOTCH1; neurogenic locus notch homolog protein 1 [KO:K02599]
101377476  NOTCH2; neurogenic locus notch homolog protein 2 [KO:K20994]
101373848  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
101383839  NOTCH4; neurogenic locus notch homolog protein 4 isoform X1 [KO:K20996]
101385029  HES1; transcription factor HES-1 [KO:K06054]
101379538  HES5; transcription factor HES-5 [KO:K06055]
101362794  HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X2 [KO:K09091]
101366966  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein [KO:K09091]
101376150  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 [KO:K09091]
101382368  FLT4; vascular endothelial growth factor receptor 3 [KO:K05097] [EC:2.7.10.1]
101374415  SHH; sonic hedgehog protein [KO:K11988]
101379447  PTCH1; protein patched homolog 1 isoform X1 [KO:K06225]
101381544  SMO; smoothened homolog [KO:K06226]
101386862  KIF7; kinesin-like protein KIF7 [KO:K18806]
101383013  SUFU; suppressor of fused homolog isoform X2 [KO:K06229]
101379429  GLI1; zinc finger protein GLI1 isoform X1 [KO:K16797]
101378177  GLI2; zinc finger protein GLI2 [KO:K16798]
101379949  GLI3; transcriptional activator GLI3 [KO:K06230]
101367237  BMP2; bone morphogenetic protein 2 [KO:K21283]
101380696  BMP4; bone morphogenetic protein 4 [KO:K04662]
101382855  HHIP; hedgehog-interacting protein [KO:K06231]
101384506  PTCH2; protein patched homolog 2 [KO:K11101]
101366368  AR; androgen receptor [KO:K08557]
101365532  HSP90AB1; heat shock protein HSP 90-beta isoform X1 [KO:K04079]
101381301  LOW QUALITY PROTEIN: heat shock protein HSP 90-alpha-like [KO:K04079]
101363592  HSP90AA1; LOW QUALITY PROTEIN: heat shock protein HSP 90-alpha [KO:K04079]
101384762  HSP90B1; endoplasmin isoform X1 [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Reference
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
Reference
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
oro03320  PPAR signaling pathway
oro04010  MAPK signaling pathway
oro04020  Calcium signaling pathway
oro04024  cAMP signaling pathway
oro04060  Cytokine-cytokine receptor interaction
oro04066  HIF-1 signaling pathway
oro04110  Cell cycle
oro04115  p53 signaling pathway
oro04150  mTOR signaling pathway
oro04151  PI3K-Akt signaling pathway
oro04210  Apoptosis
oro04310  Wnt signaling pathway
oro04330  Notch signaling pathway
oro04340  Hedgehog signaling pathway
oro04350  TGF-beta signaling pathway
oro04370  VEGF signaling pathway
oro04510  Focal adhesion
oro04512  ECM-receptor interaction
oro04520  Adherens junction
oro04630  JAK-STAT signaling pathway
oro04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system